Active Surveillance Rate for Low-Risk Prostate Cancer Is Rising
Although most men with low-risk prostate cancer are now managed initially with active surveillance, use of this approach remains suboptimal, according to investigators.
Radical Prostatectomy
Prostate Cancer PLND Might Be Avoidable in Some Men With Negative PSMA PET CT
In patients with high-risk prostate cancer, negative PSMA PET/CT does not permit PLND avoidance, investigators cautioned.
Localized Prostate Cancer Treatment Choice Does Not Harm Mental Health
Investigators compared the mental health status of men undergoing surgery, radiation therapy, and active surveillance for localized prostate cancer.
Prostate Cancer Diagnoses Plunged During First COVID-19 Lockdown in England
From March 23 to July 4, 2020, the number of men newly diagnosed with prostate cancer dropped 48.3% compared with the corresponding period in 2019, according to investigators.
Early Salvage Radiation After RP Improves Outcomes in Relapsed Prostate Cancer
Early salvage radiation therapy was defined as PSA levels of 0.2 to 0.5 ng/mL.
Neoadjuvant Abiraterone Prior to Surgery Beneficial in High-Risk Prostate Cancer
In a phase 2 trial, 44% of men who received abiraterone with or without cabazitaxel prior to radical prostatectomy for high-risk prostate cancer achieved a pathologic complete response or minimal residual disease.
LND Extent During Prostate Cancer Surgery Not Linked to Survival
A study of men with prostate cancer found no association between extent of lymph node dissection during radical prostatectomy and survival outcomes.
Same-Day Robot-Assisted Prostate Cancer Surgery Safe, Feasible
Patients who underwent robot-assisted radical prostatectomy and were discharged the same day had complication and 90-day readmission rates similar to those who had the procedure as inpatients.
Racial Disparities in Prostate Cancer Persist Despite Equal-Access Care
Equal access to care may not be sufficient to eliminate racial and ethnic disparities in prostate cancer care, according to investigators.
Nonselective Beta-Blockers May Reduce Prostate Cancer Recurrence Risk
The perioperative period is receiving increased attention as a platform to inhibit cancer progression, according to investigators.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...